Investments
171Portfolio Exits
8Funds
4About Kaitai Capital
Kaitai Capital is a venture capital management company, focusing on biotechnology and precision medicine, medical services, cultural and entertainment, leisure travel, outdoor sports, and financial services.
Want to inform investors similar to Kaitai Capital about your company?
Submit your Analyst Briefing to get in front of investors, customers, and partners on CB Insights’ platform.
Latest Kaitai Capital News
Nov 16, 2022
Kaitai Capital was the other lead investor in the round.
Kaitai Capital Investments
171 Investments
Kaitai Capital has made 171 investments. Their latest investment was in Darts Bio as part of their Series B on January 1, 2023.
Kaitai Capital Investments Activity
Date | Round | Company | Amount | New? | Co-Investors | Sources |
|---|---|---|---|---|---|---|
1/20/2023 | Series B | Darts Bio | No | 1 | ||
11/29/2022 | Series A | Rgenta Therapeutics | $52M | No | AstraZeneca CICC Healthcare, Boehringer Ingelheim Venture Fund, Delos Capital, Kaitai Capital, Korea Investment Partners, Legend Star, Matrix Partners China, Undisclosed Investors, and Vivo Capital | 12 |
11/24/2022 | Seed VC | Primelink Biotherapeutics | $14M | Yes | 5 | |
11/14/2022 | Series A - IV | |||||
11/3/2022 | Seed VC - II |
Date | 1/20/2023 | 11/29/2022 | 11/24/2022 | 11/14/2022 | 11/3/2022 |
|---|---|---|---|---|---|
Round | Series B | Series A | Seed VC | Series A - IV | Seed VC - II |
Company | Darts Bio | Rgenta Therapeutics | Primelink Biotherapeutics | ||
Amount | $52M | $14M | |||
New? | No | No | Yes | ||
Co-Investors | AstraZeneca CICC Healthcare, Boehringer Ingelheim Venture Fund, Delos Capital, Kaitai Capital, Korea Investment Partners, Legend Star, Matrix Partners China, Undisclosed Investors, and Vivo Capital | ||||
Sources | 1 | 12 | 5 |
Kaitai Capital Portfolio Exits
8 Portfolio Exits
Kaitai Capital has 8 portfolio exits. Their latest portfolio exit was Asieris Pharma on January 07, 2022.
Date | Exit | Companies | Valuation Valuations are submitted by companies, mined from state filings or news, provided by VentureSource, or based on a comparables valuation model. | Acquirer | Sources |
|---|---|---|---|---|---|
1/7/2022 | IPO | Public | 1 | ||
Date | 1/7/2022 | ||||
|---|---|---|---|---|---|
Exit | IPO | ||||
Companies | |||||
Valuation | |||||
Acquirer | Public | ||||
Sources | 1 |
Kaitai Capital Fund History
4 Fund Histories
Kaitai Capital has 4 funds, including Kaitai Clean Energy Industrial Fund.
Closing Date | Fund | Fund Type | Status | Amount | Sources |
|---|---|---|---|---|---|
11/25/2011 | Kaitai Clean Energy Industrial Fund | REAL Assets | Open | $78.7M | 1 |
Kaitai Fund I | |||||
Kaitai Fund II | |||||
Kaitai Fund IV |
Closing Date | 11/25/2011 | |||
|---|---|---|---|---|
Fund | Kaitai Clean Energy Industrial Fund | Kaitai Fund I | Kaitai Fund II | Kaitai Fund IV |
Fund Type | REAL Assets | |||
Status | Open | |||
Amount | $78.7M | |||
Sources | 1 |
Kaitai Capital Team
3 Team Members
Kaitai Capital has 3 team members, including current Chief Executive Officer, Senior Vice President, Xian Li.
Name | Work History | Title | Status |
|---|---|---|---|
Xian Li | Chief Executive Officer, Senior Vice President | Current | |
Name | Xian Li | ||
|---|---|---|---|
Work History | |||
Title | Chief Executive Officer, Senior Vice President | ||
Status | Current |
Discover the right solution for your team
The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.